Lucira Health, Inc. is a molecular diagnostics company focused on developing and commercializing point-of-care and at-home testing solutions. Founded in 2015 and headquartered in Emeryville, California, the company leverages its proprietary isothermal amplification technology to deliver rapid, accurate results outside of traditional laboratory settings. Lucira’s initial mission centered on creating user-friendly, portable diagnostic products that empower individuals and healthcare providers with timely information to manage infectious diseases.
Lucira’s flagship product is its single-use molecular test kit for the detection of SARS-CoV-2. Authorized under the U.S. Food and Drug Administration’s Emergency Use Authorization (EUA), this test delivers results in approximately 30 minutes and can be performed with minimal training. In addition to its COVID-19 test, Lucira has expanded its pipeline to include combination tests for influenza A/B and respiratory syncytial virus (RSV), aiming to address a broader range of respiratory pathogens in a single, rapid format.
The company primarily serves the United States market, with distribution channels that include healthcare institutions, pharmacies, and direct-to-consumer retail outlets. Lucira continues to pursue regulatory clearances and partnerships to extend its geographic reach and product offerings. Through collaborations with laboratory network operators and clinical research organizations, Lucira seeks to validate new applications for its platform and explore opportunities in global markets.
Under the leadership of Chief Executive Officer David J. Hutt, Lucira Health emphasizes innovation, quality control, and strategic growth. The executive team comprises seasoned professionals in diagnostics, regulatory affairs, and commercial operations, guiding the company’s efforts to scale manufacturing and expand its product portfolio. Lucira remains committed to advancing decentralized testing solutions that enhance patient access and support public health initiatives worldwide.
AI Generated. May Contain Errors.
Free LHDXQ Stock Alerts